Nesta página
KPRX Kiora Pharmaceuticals, Inc. - Common Stock
NASDAQ · Pharmaceuticals · Ver em SEC EDGAR ↗ fechar Out 2, 2026 10-K/10-Q Ago 7, 2026
$2,56
· % da faixa de 52 semanas
· acima do mínimo
· para alta
$1,77mínima 52 sem
$2,95máxima 52 sem
Capitalização de Mercado (MRQ)
$11M
P/E
-1.0
EPS
$-2.64
Receita
$0
seus distintivos
Intervalo 52 Semanas
$2–$3
Classificação do Analista
BUY
Preço-Alvo
$12
P/E
-1.0
ROE
-56.6%
Margem de Lucro Líquido
·
Sua barra de distintivos está vazia — fixe uma métrica em qualquer lugar desta página.
KPRX Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$2.56
Capitalização de Mercado (MRQ)
$11M
P/E
-1.0
EPS
$-2.64
Receita
$0
ROE
-56.6%
Intervalo 52 Semanas
$2–$3
KPRX Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
intervalo
barras
A granularidade da barra se adapta ao período selecionado — passe o mouse sobre o gráfico para ver a abertura/máxima/mínima/fechamento de uma barra.
Divisões de Ações
| Data ex | Desdobramento | Tipo |
|---|---|---|
| 11 de Junho de 2024 | 1-for-9 | Reverso |
| 27 de Setembro de 2022 | 1-for-40 | Reverso |
| 30 de Agosto de 2019 | 1-for-15 | Reverso |
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita$02016-12-31 → 2025-12-31
EPS$-2.642020-12-31 → 2025-12-31
Fluxo de caixa livre$-10M2017-12-31 → 2025-12-31
Margem líquida·2016-12-31 → 2024-12-31
Avaliação e Proporções
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
| Métrica | Tendência de 5 anos | KPRX | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| P/E | -1.0média 5A ≈-1.7 | ≈-1.7 | · | · | |
| P/B (MRQ) | 0.7média 5A ≈96.8 | ≈96.8 | 2.1 | Subvalorizado | |
| Preço / FCF (TTM) | -1.3média 5A ≈-161.5 | ≈-161.5 | · | · | |
| Preço / Fluxo de Caixa (TTM) | -1.3média 5A ≈-130.7 | ≈-130.7 | · | · | |
| Preço / Valor Patrimonial Tangível (MRQ) | 0.8média 5A ≈472.7 | ≈472.7 | · | · |
A mediana dos pares é calculada em uma base padronizada por métrica e pode não corresponder sempre à base TTM/MRQ mostrada para esta ação.
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
| Métrica | Tendência de 5 anos | KPRX | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| ROA | -35.7%média 5A ≈-49.3% | ≈-49.3% | -44.9% | Primeira linha | |
| ROE | -56.6%média 5A ≈-84.4% | ≈-84.4% | -57.2% | Em linha | |
| ROIC | -71.2%média 5A ≈-94.2% | ≈-94.2% | 348.2% | Fraco |
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
| Métrica | Tendência de 5 anos | KPRX | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Índice de liquidez corrente (MRQ) | 9.0média 5A ≈4.4 | ≈4.4 | 3.1 | Liquidez forte | |
| Índice de Liquidez Seca (MRQ) | 7.6média 5A ≈3.6 | ≈3.6 | 3.0 | Liquidez forte |
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Ainda não há dados para este grupo de rácios
Ainda não há dados fundamentais suficientes para calcular este grupo de proporções.
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
| Métrica | Tendência de 5 anos | KPRX | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Asset Turnover (Giro do Ativo) | 0.0média 5A ≈0.2 | ≈0.2 | 0.1 | Fraco | |
| Receivables Turnover (Giro de Contas a Receber) | 0.0 | · | 4.5 | Fraco | |
| Revenue / Employee (Receita anual ÷ funcionários (número de funcionários reportado, yfinance). Derivado — não é um conceito SEC-XBRL armazenado.) | ≈$0.00 | · | · | · |
valor · ≈ média 5A · mediana do setor · veredicto relativo à mediana
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
-2.0%
Próximo relatório
Nov 05, 2026
| Período | Relatório | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|---|
| 30 de Junho de 2026 | Ago 6, 2026 | $-0.34 | $-0.63 | 46.2% |
| 31 de Março de 2026 | Mai 7, 2026 | $-0.58 | $-0.72 | 19.9% |
| 31 de Dezembro de 2025 | $-1.59 | $-0.68 | -132.7% | |
| 30 de Setembro de 2025 | $0.01 | $-0.75 | 101.3% | |
| 30 de Junho de 2025 | $-0.54 | $-0.62 | 12.5% | |
| 31 de Março de 2025 | $-0.52 | $-0.68 | 23.9% | |
| 31 de Dezembro de 2024 | $-1.04 | $-0.56 | -85.4% |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $16M | $0 | · | $0 | $12.1K | $3M | $2M | $407.5K | $669.3K | $0 | |
| R&D Expense | $11M | $8M | $4M | $3M | $5M | $4M | $5M | $8M | $10M | $8M | $3M | |
| SG&A Expense | $6M | $6M | $5M | $8M | $5M | $5M | $4M | $4M | $5M | $6M | $4M | |
| Operating Expenses | $13M | $12M | $13M | $12M | $14M | $7M | $10M | $12M | $15M | $14M | $7M | |
| Operating Income | $-13M | $5M | $-13M | $-12M | $-14M | $-7M | · | $-11M | · | · | · | |
| Interest Expense | · | · | $11.1K | $8.6K | $6.9K | $4.2K | $325 | $1.0K | $1.2K | $275 | $2M | |
| Interest Income | $894.0K | $1M | $174.0K | $56.9K | $1.1K | $23.3K | $108.1K | $120.4K | $564 | $3.7K | $947 | |
| Other Non-op | $-160.3K | $26.1K | $28.8K | $-14.5K | $272.5K | $19.2K | $107.7K | $119.3K | $-651 | $3.4K | $10 | |
| Pretax Income | $-12M | $6M | $-12M | $-14M | $-14M | $-7M | $-7M | $-11M | $-15M | $-13M | $-8M | |
| Income Tax | $-1M | $2M | $90.3K | $-113.0K | $-192.6K | $12.1K | $95.4K | $86.0K | $-1M | $0 | · | |
| Net Income | $-11M | $4M | $-13M | $-14M | $-14M | $-7M | $-7M | $-11M | $-13M | $-13M | $-8M | |
| EPS (Basic) | $-2.60 | $0.93 | $-24.25 | $-18.55 | $-57.12 | $-1.49 | · | · | · | · | · | |
| EPS (Diluted) | $-2.64 | $0.87 | $-24.25 | $-18.55 | $-57.12 | $-1.49 | · | · | · | · | · | |
| Shares (Basic) | 4,166,692 | 3,872,644 | 538,007 | 732,303 | 241,099 | 4,591,491 | · | · | · | · | · | |
| Shares (Diluted) | 4,103,873 | 4,125,075 | 538,007 | 732,303 | 241,099 | 4,591,491 | · | · | · | · | · | |
| EBITDA | $-13M | $5M | $-13M | $-12M | $-14M | $33.4K | $51.7K | $-11M | $19.3K | $5.2K | $1.3K |
Balanço Patrimonial
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9M | $4M | $2M | $6M | $8M | $1M | $4M | $8M | $8M | $4M | $8M | |
| Short-term Investments | $8M | $23M | $0 | · | · | · | · | · | · | · | · | |
| Receivables | $2M | $601.2K | $0 | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $1M | $2M | $233.4K | $343.1K | $606.5K | $449.6K | $458.8K | $455.8K | $629.6K | $465.0K | $122.4K | |
| Current Assets | $22M | $30M | $5M | $8M | $9M | $2M | $4M | $8M | $8M | $4M | $9M | |
| PP&E (Net) | $91.7K | $5.2K | $8.1K | $55.2K | $74.0K | $30.6K | $16.8K | $43.5K | $55.8K | $38.0K | $0 | |
| PP&E (Gross) | $117.6K | $6.3K | $14.4K | $172.5K | $187.1K | $123.5K | $99.6K | $99.6K | $79.6K | $42.6K | $268.1K | |
| Accum. Depreciation | $25.9K | $1.0K | $6.3K | $117.3K | $113.1K | $93.0K | $82.7K | $56.1K | $23.8K | $4.5K | $268.1K | |
| Goodwill | · | · | · | $0 | $0 | $4M | $2M | $2M | $2M | · | · | |
| Intangibles | $2M | $7M | $9M | $11M | $11M | $10M | $4M | $4M | $4M | · | · | |
| Other Non-current Assets | $59.7K | $24.9K | $40.8K | $33.0K | $43.0K | $57.1K | $69.4K | $31.7K | $307.1K | $55.3K | $38.6K | |
| Total Assets | $24M | $36M | $14M | $19M | $20M | $15M | $10M | $14M | $14M | $10M | $10M | |
| Accounts Payable | $1M | $415.6K | $206.3K | $1M | $160.6K | $434.8K | $210.3K | $63.7K | $706.1K | $1M | $417.7K | |
| Accrued Liabilities | $2M | $5M | $1M | $2M | $1M | $1M | $1M | $1M | $2M | $2M | $1M | |
| Short-term Debt | · | · | · | · | · | $212.3K | · | · | · | · | · | |
| Current Liabilities | $4M | $6M | $2M | $3M | $2M | $2M | $1M | $4M | $15M | $7M | $3M | |
| Capital Leases | $203.8K | $33.8K | $59.8K | $0 | $90.6K | $35.6K | $0 | $0 | $4.9K | $16.1K | $0 | |
| Deferred Tax | $102.2K | $490.7K | $779.4K | $689.1K | $802.1K | $728.9K | $365.4K | $270.0K | $183.9K | $2M | $0 | |
| Total Liabilities | $8M | $11M | $8M | $7M | $6M | $6M | $3M | $5M | $16M | $10M | $3M | |
| Total Debt | · | · | · | · | · | $278.2K | · | · | · | · | · | |
| Common Stock | $275.3K | $267.7K | $77.1K | $18.0K | $3.2K | $55.6K | $40.8K | $30.4K | $172.6K | $101.3K | $76.6K | |
| Paid-in Capital | $170M | $169M | $153M | $146M | $136M | $117M | $107M | $102M | $90M | $78M | $71M | |
| Retained Earnings | $-154M | $-143M | $-147M | $-134M | $-121M | $-107M | $-100M | $-93M | $-92M | $-79M | $-65M | |
| AOCI | $-246.1K | $-282.2K | $-182.8K | $-182.7K | $-86.4K | $-802 | $139.5K | $134.3K | $127.5K | $120.2K | $114.8K | |
| Stockholders' Equity | $16M | $26M | $6M | $11M | $15M | $10M | $7M | $9M | $-2M | $-329.4K | $6M | |
| Liabilities + Equity | $24M | $36M | $14M | $19M | $20M | $15M | $10M | $14M | $14M | $10M | $10M | |
| Shares Outstanding | 3,761,739 | 3,000,788 | 856,182 | 1,796,472 | 316,599 | 5,556,394 | 4,077,755 | 3,038,592 | 17,257,255 | 10,130,883 | 7,657,287 |
Fluxo de Caixa
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $24.8K | $19.2K | $51.8K | $41.6K | $45.3K | $33.4K | $51.7K | $38.5K | $19.3K | $5.2K | $1.3K | |
| Stock-based Comp | $900.2K | $656.6K | $754.9K | $462.4K | $842.5K | $723.9K | $852.2K | $875.3K | $870.3K | $511.0K | $1M | |
| Deferred Tax | · | · | $90.3K | $-113.0K | $-192.6K | $-12.1K | $-95.4K | $-86.0K | $1M | $0 | · | |
| Amort. of Intangibles | $0 | $15.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $6.2K | $0 | · | · | |
| Other Non-cash | $-51.1K | $4M | $2M | $3M | $2M | $29.6K | $-2M | $-860.8K | $7M | $4M | $3M | |
| Operating Cash Flow | $-10M | $9M | $-10M | $-10M | $-11M | $-7M | $-8M | $-11M | $-6M | $-8M | $-4M | |
| CapEx | $110.8K | $6.3K | $0 | $0 | $63.9K | $20.1K | $0 | $20.0K | $37.0K | $0 | · | |
| Investing Cash Flow | $14M | $-23M | $0 | $6.4K | $-157.0K | $-244.4K | $0 | $-270.0K | $-37.0K | $174.7K | · | |
| Debt Issued | · | · | · | · | $0 | $278.2K | $0 | · | · | · | · | |
| Net Debt Issued | · | · | · | · | $0 | $278.2K | · | · | · | · | · | |
| Stock Issued | · | · | · | $5M | $18M | $5M | $2M | $10M | $11M | $4M | $14M | |
| Net Stock Activity | · | · | · | $5M | $19M | $5M | $2M | $10M | $12M | $4M | · | |
| Financing Cash Flow | $265.7K | $15M | $6M | $9M | $18M | $5M | $4M | $11M | $11M | $3M | · | |
| Net Change in Cash | $5M | $1M | $-4M | $-2M | $7M | $-3M | $-4M | $198.2K | $4M | $-5M | $8M | |
| Taxes Paid | $2M | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-10M | $9M | · | $-10M | $-11M | $-7M | · | $-11M | $-7M | · | · | |
| Levered FCF | · | · | · | $-10M | $-11M | $-7M | · | $-11M | $-7M | · | · |
Lucratividade
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | 28.1% | · | · | · | · | · | -656.2% | · | · | · | |
| Net Margin | · | 22.4% | · | · | · | -67102.9% | -264.2% | -654.2% | -3243.5% | -1993.8% | · | |
| Pretax Margin | · | 35.3% | · | · | · | -67002.9% | -260.7% | -649.0% | -3572.8% | -1993.8% | · | |
| EBITDA Margin | · | 28.3% | · | · | · | 277.0% | 1.9% | -653.9% | 4.7% | 0.77% | · | |
| ROA | -35.7% | 14.3% | -77.3% | -70.0% | -77.7% | -64.0% | -58.2% | -75.6% | -110.0% | -138.7% | -153.7% | |
| ROE | -56.6% | 12.9% | -176.1% | -123.9% | -78.5% | -124.9% | -119.9% | -107.9% | 1171.6% | -463.5% | 41.2% | |
| ROIC | -71.2% | 11.1% | -207.5% | -107.0% | -96.3% | · | · | -122.3% | · | · | · |
Liquidez e Solvência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.0 | 4.9 | 2.9 | 2.3 | 5.6 | 1.0 | 3.1 | 2.2 | 0.6 | 0.6 | 2.8 | |
| Quick Ratio | 5.1 | 4.6 | 1.5 | 1.8 | 4.9 | 0.7 | 2.7 | 2.1 | 0.5 | 0.5 | 2.5 | |
| Debt / Equity | · | · | · | · | · | 0.0 | · | · | · | · | · | |
| LT Debt / Equity | · | · | · | · | · | 0.0 | · | · | · | · | · | |
| Interest Coverage | · | · | -1130.7 | -1431.5 | -2077.9 | · | · | -10427.6 | · | · | · |
Eficiência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.6 | · | · | 0.0 | 0.0 | 0.2 | 0.1 | 0.0 | 0.1 | · | |
| Receivables Turnover | 0.0 | 53.3 | · | · | · | · | · | · | · | · | · |
Por Ação
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.29 | $8.58 | $0.79 | $6.35 | $1.15 | $1.26 | $1.62 | $0.20 | $-0.11 | $-0.03 | $0.79 | |
| Revenue / Share | $0.00 | $3.88 | · | · | $0.00 | · | · | · | · | · | · | |
| Cash Flow / Share | $-2.43 | $2.07 | $-1.97 | $-14.24 | $-1.11 | · | · | · | · | · | · | |
| Cash / Share | $2.31 | $1.26 | $0.32 | $3.32 | $0.62 | $0.21 | $0.93 | $0.18 | $0.45 | $0.36 | $1.10 | |
| EPS (TTM) | $-2.64 | $0.87 | $-24.25 | $-18.55 | $-57.12 | $-1.49 | · | · | · | · | · |
Avaliação (TTM)
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $16M | $0 | $0 | $0 | $12.1K | $3M | $2M | $407.5K | $669.3K | $0 | |
| Net Income TTM | $-11M | $4M | $-13M | $-14M | $-14M | $-7M | $-7M | $-11M | $-13M | $-13M | $-8M | |
| Market Cap | $7M | $10M | $36M | $55M | $6.88B | $9.86B | $14.71B | $109.97B | $99.71B | $89.17B | $113.30B | |
| Enterprise Value | · | · | · | · | · | $9.86B | · | · | · | · | · | |
| P/E | -0.7 | 3.8 | -0.2 | -1.7 | -9.5 | -1191.1 | · | · | · | · | · | |
| P/S | · | 0.6 | · | · | · | 817770.0 | 5476.3 | 66544.7 | 244682.2 | 133239.9 | · | |
| P/B | 0.5 | 0.4 | 5.9 | 4.9 | 472.2 | 1408.9 | 2221.1 | 12305.6 | -51747.0 | -270693.2 | 18613.7 | |
| P / Tangible Book | 0.5 | 0.5 | · | 83.5 | 1806.4 | · | · | · | · | · | · | |
| P / Cash Flow | -0.7 | 1.2 | -3.8 | -5.3 | -644.9 | -1347.7 | -1804.0 | -10140.3 | -15415.0 | -10599.1 | -25407.7 | |
| P / FCF | -0.7 | 1.2 | · | -5.3 | -641.0 | -1344.0 | · | -10121.6 | -15327.3 | · | · | |
| EV / EBITDA | · | · | · | · | · | 295235.8 | · | · | · | · | · | |
| EV / FCF | · | · | · | · | · | -1343.9 | · | · | · | · | · | |
| EV / Revenue | · | · | · | · | · | 817694.7 | · | · | · | · | · | |
| Earnings Yield | -134.0% | 26.4% | -516.2% | -60.1% | -10.5% | -0.08% | · | · | · | · | · |
Demonstração de Resultados
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $20.0K | $16M | $0 | $0 | $0 | $0 | · | · | |
| R&D Expense | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $438.3K | $841.6K | $1M | |
| SG&A Expense | $1M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $1M | $880.5K | $1M | $1M | $1M | $3M | $2M | |
| Operating Expenses | $2M | $3M | $7M | $794.4K | $2M | $2M | $3M | $4M | $3M | $3M | $2M | $6M | $3M | $2M | $3M | $4M | |
| Operating Income | $-2M | $-3M | $-7M | $-794.4K | $-2M | $-2M | $-3M | $-4M | $-3M | $13M | $-2M | $-6M | $-3M | $-2M | $-3M | $-4M | |
| Interest Income | · | · | · | · | $225.2K | $277.3K | · | · | $342.1K | $223.2K | · | · | · | · | · | · | |
| Other Non-op | $-11.5K | $-47.1K | $-26.8K | $-23.7K | $-93.6K | $-16.3K | $96.8K | $-59.9K | $-18.9K | $8.1K | $-65.7K | $105.7K | $-25.9K | $14.7K | $-15.4K | $937 | |
| Pretax Income | $-2M | $-2M | $-7M | $-616.3K | $-2M | $-2M | $-2M | $-3M | $-2M | $13M | · | · | · | · | · | · | |
| Income Tax | $0 | $0 | $-650.0K | $-643.1K | $-112.1K | $123.0K | $2M | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Income | $-2M | $-2M | $-7M | $26.8K | $-2M | $-2M | $-4M | $-3M | $-2M | $13M | $-2M | $-6M | $-3M | $-2M | $-2M | $-5M | |
| EPS (Basic) | $-0.34 | $-0.58 | $-1.55 | $0.01 | $-0.54 | $-0.52 | $-2.40 | $-0.81 | $-0.53 | $4.67 | $-8.80 | $-7.30 | $-7.15 | $-1.00 | $-1.07 | $-6.03 | |
| EPS (Diluted) | $-0.34 | $-0.58 | $-1.59 | $0.01 | $-0.54 | $-0.52 | $-1.25 | $-0.81 | $-0.53 | $3.46 | $-8.80 | $-7.30 | $-7.15 | $-1.00 | $-1.07 | $-6.03 | |
| Shares (Basic) | 6,177,679 | 4,174,802 | · | 4,289,853 | 3,989,042 | 4,217,007 | · | 4,214,950 | 4,170,627 | 2,881,796 | · | 789,656 | 365,530 | 1,863,466 | · | 848,534 | |
| Shares (Diluted) | 6,177,679 | 4,174,802 | · | 4,361,740 | 3,989,042 | 4,217,007 | · | 4,214,950 | 4,170,627 | 3,891,722 | · | 789,656 | 365,530 | 1,863,466 | · | 848,534 | |
| EBITDA | $-2M | $-2M | · | $-794.4K | $-2M | $-2M | · | $-4M | $-3M | $13M | · | $-6M | $-3M | $-2M | · | $-4M |
Balanço Patrimonial
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7M | $11M | $9M | $6M | $1M | $4M | $4M | $6M | $7M | $31M | $2M | $5M | $8M | $3M | $6M | $5M | |
| Short-term Investments | $10M | $3M | $8M | $14M | $20M | $20M | $23M | $23M | $21M | · | $0 | · | · | · | · | · | |
| Receivables | $1M | $2M | $2M | $1M | $2M | $1M | $601.2K | $2M | $1M | $189.9K | $0 | · | · | · | · | · | |
| Prepaid Expense | $1M | $1M | $1M | $650.4K | $957.1K | $941.5K | $2M | $470.4K | $339.6K | $206.7K | $233.4K | $239.4K | $266.5K | $488.9K | $343.1K | $260.0K | |
| Current Assets | $21M | $19M | $22M | $23M | $25M | $27M | $30M | $32M | $32M | $33M | $5M | $7M | $9M | $6M | $8M | $7M | |
| PP&E (Net) | $99.6K | $86.8K | $91.7K | $101.8K | $106.8K | $5.0K | $5.2K | $62.6K | $63.5K | $12.9K | $8.1K | $38.6K | $44.9K | $51.3K | $55.2K | $59.2K | |
| PP&E (Gross) | · | · | $117.6K | · | · | · | $6.3K | · | · | · | $14.4K | · | · | · | $172.5K | · | |
| Accum. Depreciation | · | · | $25.9K | · | · | · | $1.0K | · | · | · | $6.3K | · | · | · | $117.3K | · | |
| Intangibles | $2M | $2M | $2M | $7M | $7M | $7M | $7M | $7M | $9M | $9M | $9M | $9M | $11M | $11M | $11M | $11M | |
| Other Non-current Assets | $85.4K | $88.2K | $59.7K | $58.1K | $61.0K | $64.3K | $24.9K | $29.9K | $32.1K | $39.4K | $40.8K | $32.0K | $32.4K | $32.7K | $33.0K | $33.0K | |
| Total Assets | $24M | $21M | $24M | $30M | $32M | $34M | $36M | $39M | $41M | $42M | $14M | $16M | $20M | $17M | $19M | $18M | |
| Accounts Payable | $216.5K | $594.9K | $1M | $241.5K | $282.5K | $942.5K | $415.6K | $660.4K | $268.6K | $323.1K | $206.3K | $125.4K | $131.3K | $587.5K | $1M | $749.2K | |
| Accrued Liabilities | $2M | $2M | $2M | $2M | $3M | $4M | $5M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | |
| Current Liabilities | $2M | $3M | $4M | $3M | $3M | $5M | $6M | $4M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | |
| Capital Leases | $160.6K | $195.4K | $203.8K | $248.2K | $287.1K | $87.5K | $33.8K | $39.2K | $40.2K | $46.4K | $59.8K | $0 | $0 | $0 | $0 | $4.8K | |
| Deferred Tax | $102.2K | $102.2K | $102.2K | $490.7K | $490.7K | $490.7K | $490.7K | $779.4K | $779.4K | $779.4K | $779.4K | $689.1K | $689.1K | $689.1K | $689.1K | $802.1K | |
| Total Liabilities | $7M | $7M | $8M | $7M | $10M | $10M | $11M | $8M | $8M | $8M | $8M | $8M | $6M | $6M | $7M | $7M | |
| Common Stock | $281.9K | $277.6K | $275.3K | $272.0K | $272.0K | $267.7K | $267.7K | $267.7K | $267.4K | $262.6K | $77.1K | $76.9K | $69.1K | $19.2K | $18.0K | $10.8K | |
| Paid-in Capital | $176M | $171M | $170M | $170M | $170M | $169M | $169M | $169M | $169M | $168M | $153M | $153M | $153M | $147M | $146M | $143M | |
| Retained Earnings | $-159M | $-157M | $-154M | $-148M | $-148M | $-146M | $-143M | $-139M | $-136M | $-134M | $-147M | $-145M | $-139M | $-136M | $-134M | $-132M | |
| AOCI | $-255.8K | $-228.8K | $-246.1K | $-243.7K | $-245.8K | $-297.2K | $-282.2K | $-75.2K | $-245.7K | $-264.4K | $-182.8K | $-266.2K | $-225.9K | $-215.4K | $-182.7K | $-263.4K | |
| Stockholders' Equity | $17M | $14M | $16M | $22M | $22M | $24M | $26M | $30M | $33M | $35M | $6M | $8M | $14M | $10M | $11M | $11M | |
| Liabilities + Equity | $24M | $21M | $24M | $30M | $32M | $34M | $36M | $39M | $41M | $42M | $14M | $16M | $20M | $17M | $19M | $18M | |
| Shares Outstanding | 4,427,167 | 3,993,469 | 3,761,739 | 3,433,491 | 3,433,491 | 3,000,788 | 3,000,788 | 3,000,788 | 2,970,545 | 26,256,197 | 856,182 | 7,689,240 | 6,910,720 | 1,919,270 | 1,796,472 | 1,079,045 |
Fluxo de Caixa
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $10.7K | $10.6K | $10.5K | $10.6K | $3.4K | $318 | $5.9K | $2.1K | $6.3K | $4.9K | $7.9K | $11.3K | $22.5K | $10.1K | $10.3K | $10.3K | |
| Stock-based Comp | $109.3K | $209.5K | $234.4K | $254.4K | $262.8K | $148.6K | $160.2K | $171.2K | $149.8K | $175.4K | $182.3K | $264.9K | $171.8K | $135.9K | $45.1K | $130.2K | |
| Other Non-cash | · | $-963.4K | · | · | · | $-660.2K | · | · | · | $-8.7K | · | · | · | $-1M | · | · | |
| Operating Cash Flow | $-2M | $-3M | $-2M | $-1M | $-4M | $-3M | $-2M | $920.1K | $-4M | $14M | $-3M | $-3M | $-1M | $-3M | $-2M | $-3M | |
| CapEx | $23.5K | $5.0K | $78.2K | $431 | $32.2K | $0 | $-45.0K | $0 | · | · | $0 | $0 | · | · | · | · | |
| Investing Cash Flow | $-7M | $5M | $5M | $6M | $664.2K | $3M | $482.7K | $-2M | $-21M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Stock Issued | · | · | · | · | · | · | · | $0 | $0 | $0 | · | $0 | $343.4K | $99.0K | · | $5M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $99.0K | · | · | |
| Financing Cash Flow | $5M | $-842 | $296 | $0 | $265.4K | $0 | $0 | $0 | $250.5K | $15M | $-486.4K | $0 | $6M | $513.2K | $3M | $5M | |
| Net Change in Cash | $-4M | $2M | $3M | $4M | $-3M | $-21.3K | $-2M | $-938.0K | $-25M | $29M | $-3M | $-3M | $5M | $-3M | $1M | $2M | |
| Free Cash Flow | · | $-3M | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Lucratividade
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | -12724.4% | 82.6% | · | -11858.0% | -5839.8% | -5727.4% | · | -47106.4% | |
| Net Margin | · | · | · | · | · | · | · | · | -11108.2% | 84.1% | · | -11546.2% | -5797.3% | -5583.6% | · | -65123.2% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | -12724.4% | 82.7% | · | -11858.0% | -5839.8% | -5697.3% | · | -47106.4% | |
| ROA | -7.5% | -8.8% | · | 0.08% | -5.9% | -5.7% | · | -12.6% | -7.3% | 45.6% | · | -34.4% | -14.8% | -10.9% | · | -23.7% | |
| ROE | -10.7% | -12.8% | · | 0.10% | -7.8% | -7.5% | · | -17.9% | -9.5% | 59.7% | · | -61.9% | -23.3% | -17.4% | · | -36.7% | |
| ROIC | -13.1% | -18.0% | · | 0.15% | -10.3% | -10.4% | · | · | · | · | · | · | · | · | · | · |
Liquidez e Solvência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.0 | 6.7 | · | 8.8 | 7.8 | 5.1 | · | 9.0 | 19.2 | 21.0 | · | 3.3 | 4.8 | 2.6 | · | 2.2 | |
| Quick Ratio | 7.6 | 5.5 | · | 8.0 | 7.2 | 4.8 | · | 8.7 | 17.6 | 19.8 | · | 2.6 | 4.2 | 1.6 | · | 1.6 |
Eficiência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.5 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 168.5 | · | · | · | · | · | · |
Por Ação
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.81 | $3.49 | · | $6.53 | $6.44 | $7.90 | · | $10.01 | $11.14 | $1.33 | · | $1.05 | $1.97 | $5.29 | · | $9.75 | |
| Revenue / Share | · | · | · | $0.00 | $0.00 | $0.00 | · | $0.00 | $0.00 | $0.46 | · | $0.01 | $0.01 | $0.02 | · | $0.01 | |
| Cash Flow / Share | · | $-0.76 | · | · | · | $-0.64 | · | · | · | $0.39 | · | · | · | $-1.65 | · | · | |
| Cash / Share | $1.60 | $2.74 | · | $1.60 | $0.30 | $1.26 | · | $1.88 | $2.21 | $1.19 | · | $0.70 | $1.15 | $1.79 | · | $4.45 | |
| EPS (TTM) | $-2.50 | $-2.70 | · | $-2.30 | $-3.12 | $-3.11 | · | $-6.68 | $-13.17 | $-19.79 | · | $-16.52 | $-15.25 | $-8.28 | · | $-62.65 |
Avaliação (TTM)
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $20.0K | · | $16M | $16M | $16M | · | · | · | · | · | $12.1K | |
| Net Income TTM | $-11M | $-11M | · | $-9M | $-12M | $-12M | · | $6M | $3M | $3M | · | $-13M | $-12M | $-12M | · | $-17M | |
| Market Cap | $12M | $8M | · | $10M | $10M | $9M | · | $11M | $12M | $167M | · | $39M | $40M | $58M | · | $60M | |
| P/E | -1.1 | -0.7 | · | -1.2 | -0.9 | -1.0 | · | -0.5 | -0.3 | -0.3 | · | -0.3 | -0.4 | -3.6 | · | -0.9 | |
| P/S | · | · | · | · | · | 451.6 | · | 0.7 | 0.8 | 10.4 | · | · | · | · | · | 4952.7 | |
| P/B | 0.7 | 0.6 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 4.8 | · | 4.9 | 2.9 | 5.7 | · | 5.7 | |
| P / Tangible Book | 0.8 | 0.6 | · | 0.6 | 0.6 | 0.5 | · | 0.5 | 0.5 | 6.4 | · | · | 13.7 | · | · | · | |
| P / Cash Flow | · | -2.4 | · | · | · | -3.3 | · | · | · | 12.2 | · | · | · | -18.8 | · | · | |
| Earnings Yield | -95.1% | -139.9% | · | -82.7% | -108.3% | -103.3% | · | -182.5% | -313.6% | -311.5% | · | -323.2% | -263.5% | -27.5% | · | -113.2% |
Período mais recente à esquerda · valores nulos mostrados como ·
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Receita | $0 | $16M | $0 | · | $0 |
| Margem Operacional % | · | 28.1% | · | · | · |
| Lucro líquido | $-11M | $4M | $-13M | $-14M | $-14M |
| EPS Diluído | $-2.64 | $0.87 | $-24.25 | $-18.55 | $-57.12 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Índice de liquidez corrente | 6.0 | 4.9 | 2.9 | 2.3 | 5.6 |
| Índice de Liquidez Seca | 5.1 | 4.6 | 1.5 | 1.8 | 4.9 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $-10M | $9M | · | $-10M | $-11M |
Investidores institucionais (13F) 23 declarantes · $2.8M total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Detentores
23
Valor detido
$2.8M
Novas posições
10
Posições encerradas
6
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 10 (+3 vs trimestre anterior) | 6 (0 vs trimestre anterior) | 3 (-1 vs trimestre anterior) | 2 (+1 vs trimestre anterior) | +766K |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | $1.153.179 | 438.471 | 40,91% | Ações |
| ADAR1 Capital Management, LLC | $441.685 | 167.941 | 15,67% | Ações |
| CITADEL ADVISORS LLC | $305.109 | 116.011 | 10,82% | Ações |
| TWO SIGMA INVESTMENTS, LP | $233.523 | 88.792 | 8,28% | Ações |
| MILLENNIUM MANAGEMENT LLC | $195.151 | 74.202 | 6,92% | Ações |
| RENAISSANCE TECHNOLOGIES LLC | $78.437 | 29.824 | 2,78% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $70.264 | 26.717 | 2,49% | Ações |
| VANGUARD GROUP INC | $65.189 | 33.091 | 2,31% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $52.234 | 19.861 | 1,85% | Ações |
| Scientech Research LLC | $49.302 | 18.746 | 1,75% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $34.269 | 13.030 | 1,22% | Ações |
| LPL Financial LLC | $32.875 | 12.500 | 1,17% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $31.923 | 12.138 | 1,13% | Ações |
| NORTHERN TRUST CORP | $30.947 | 11.767 | 1,10% | Ações |
| JANE STREET GROUP, LLC | $27.918 | 10.615 | 0,99% | Ações |
| UBS Group AG | $5.157 | 1.961 | 0,18% | Ações |
| Caitong International Asset Management Co., Ltd | $4.768 | 1.813 | 0,17% | Ações |
| MORGAN STANLEY | $3.703 | 1.408 | 0,13% | Ações |
| Tower Research Capital LLC (TRC) | $2.201 | 837 | 0,08% | Ações |
| SBI Securities Co., Ltd. | $673 | 256 | 0,02% | Ações |
| HRT FINANCIAL LP | $154 | 58.612 | 0,01% | Ações |
| BlackRock, Inc. | $153 | 58 | 0,01% | Ações |
| Activest Wealth Management | $5 | 2 | 0,00% | Ações |
Ativistas e proprietários de 5%+ 5 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Armistice Capital, LLC, Steven Boyd ×10 declarações | 3 de Agosto de 2021 | · | Declaração inicial | Campanha no conselho | SEC |
| IPSA (formerly Innoven Partenaires S.A.), FCPI Innoven Europe, FCPI Innoven Europe 2, FCPI Innoven Capital 2, FCPI Poste Innovation 3, FCPI Poste Innovation 5, FCPI Poste Innovation 6, FCPI La Banque Postale Innovation 1, Jean-Michel Paulhac ×3 declarações | 17 de Janeiro de 2018 | · | Declaração inicial | Investimento passivo | SEC |
| Innoven Partenaires S.A. (IPSA), Innoven 2002 FCPI N°6, Innoven 2003 FCPI N°7, FCPI Innoven Europe, FCPI Innoven Europe 2, FCPI Innoven Europe 3, FCPI Innoven Capital, FCPI Innoven Capital 2, FCPI Poste Innovation, FCPI Poste Innovation 2, FCPI Poste Innovation 3, FCPI Poste Innovation 5, FCPI Poste Innovation 6, FCPI Poste Innovation 9, FCPI La Banque Postale Innovation 1, Jean-Michel Paulhac, Thomas Balland ×2 declarações | 16 de Junho de 2017 | · | Declaração inicial | Investimento passivo | SEC |
| FCPR Ventech A, FCPR Ventech B, FCPR Ventech Coinvest, FCPR Ventech Capital II, Alain Caffi, Jean Bourcereau ×2 declarações | 16 de Junho de 2017 | · | Declaração inicial | Investimento passivo | SEC |
| Stephen From | 4 de Março de 2015 | · | Declaração inicial | Investimento passivo | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Executivos da empresa 29 insiders · 9 diretores · 13 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Brian M. Strem | President and CEO | 1 de Julho de 2026 F | 58.823 | 0 | 0 | $0 |
| Melissa Tosca | CFO | 1 de Julho de 2026 F | 26.064 | 0 | 0 | $0 |
| Sarah Romano | Chief Financial Officer | 10 de Fevereiro de 2022 F | 22.746 | 0 | 0 | $0 |
| Ryan Randall Brenneman | Chief Financial Officer | 18 de Julho de 2016 A | · | 0 | 0 | $0 |
| Stephen From | Executive Chairman | 5 de Janeiro de 2022 F | 67.693 | 0 | 0 | $0 |
| Brenda Mann | VP of Research & Development | 2 de Novembro de 2021 F | 15.136 | 0 | 0 | $0 |
| MANZO MICHAEL P. | VP of Engineering | 3 de Agosto de 2021 F | 15.378 | 0 | 0 | $0 |
| Barbara Wirostko | Chief Medical Officer | 6 de Agosto de 2019 F | 403.893 | 0 | 0 | $0 |
| Michael Garanzini | Chief Commercial Officer | 10 de Julho de 2018 A | 196.250 | 0 | 0 | $0 |
| Erin Parsons | Conselheiro | 10 de Junho de 2026 A | 5.260 | 0 | 0 | $0 |
| Carmine N. Stengone | Conselheiro | 10 de Junho de 2026 A | 1.250 | 0 | 0 | $0 |
| Aron Shapiro | Conselheiro | 10 de Junho de 2026 A | 3.000 | 0 | 0 | $0 |
| David Hollander | Conselheiro | 10 de Junho de 2026 A | · | 0 | 0 | $0 |
| Lisa Walters-Hoffert | Conselheiro | 10 de Junho de 2026 A | 1.250 | 0 | 0 | $0 |
| Praveen Tyle | Conselheiro | 10 de Junho de 2026 A | 5.014 | 0 | 0 | $0 |
| Morton Goldberg | Conselheiro | 1 de Fevereiro de 2021 A | 0 | 0 | 0 | $0 |
| Thomas Hancock | Conselheiro | 1 de Fevereiro de 2021 A | 13.487 | 0 | 0 | $0 |
| Peter Greenleaf | Conselheiro | 1 de Fevereiro de 2019 A | · | 0 | 0 | $0 |
| Thomas Balland | Conselheiro | 21 de Junho de 2017 A | 10.422 | 0 | 0 | $0 |
| Mounia Chaoui | Conselheiro | 29 de Março de 2016 A | 10.422 | 0 | 0 | $0 |
| Ventech Capital II | Detentor de 10% | 13 de Março de 2017 S | 1.431.814 | 0 | 0 | $0 |
| NATIXIS PRIVATE EQUITY | Detentor de 10% | 19 de Fevereiro de 2015 C | 674.205 | 0 | 0 | $0 |
| IPSA (INNOVEN PARTENAIRES S.A.) | Detentor de 10% | 19 de Fevereiro de 2015 C | 1.460.479 | 0 | 0 | $0 |
| Keith J. Lane | · | 17 de Setembro de 2026 A | · | 0 | 0 | $0 |
| Eric Joseph Daniels | · | 1 de Abril de 2026 F | 31.741 | 0 | 0 | $0 |
| Kenneth L Gayron | · | 29 de Setembro de 2023 A | · | 0 | 0 | $0 |
| Paul G Chaney | · | 3 de Março de 2023 A | 91.229 | 0 | 0 | $0 |
| Franz Obermayr | · | 1 de Fevereiro de 2021 A | · | 0 | 0 | $0 |
| Bernard Malfroy-Camine | · | 1 de Fevereiro de 2021 A | 61.525 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Participação em ETFs Detido por 3 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
KPRX Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
classificação · 7 analistas
COMPRA
Alvo mediano
$12.00
+368,7%
2 28,6%
Compra forte
4 57,1%
Compra
1 14,3%
Manter
0 0,0%
Venda
0 0,0%
Venda forte
Preço-alvo de 12 meses
1 analistas · 2026-10-03Alvo médio $12.00 +368,7%
Mín$12.00
Média$12.00
Máx$12.00
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
Base do ano fiscal, preços no fechamento do último ano fiscal de cada empresa.
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| KPRX | $7M | -0.7 | · | · | -56.6% | · |
| TVRD | $40M | -1.3 | -66.0% | · | -67.6% | · |
| BFRI | · | · | · | · | · | · |
| CTXR | · | -0.4 | · | · | · | · |
| HIND | $20M | -0.7 | 24.4% | -3209.7% | -411.1% | 68.4% |
| ADIL | $244.4K | -0.0 | · | · | -146.8% | · |
| CALC | · | -3.3 | -29.7% | · | · | · |
| TRAW | · | 1.4 | 1134.5% | · | · | · |
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para si — clique no + ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Fonte: SEC 10-Q arquivado Ago 7, 2026